Category: Health Care

AstraZeneca last week announced the approval by the U.S. Food and Drug Administration of IMFINZI. The drug treats Stage III non-small cell lung cancer. “The approval of IMFINZI in this earlier stage of non-small cell lung cancer is a truly meaningful milestone for patients who, until now, had no FDA-approved treatment options following chemoradiation therapy,”…

New Castle County has hired the law firm Motley Rice to explore taking action against the pharmaceutical industry for its role in the opioid crisis. “The conduct of multi-billion dollar pharmaceutical companies has caused significant pain and cost so many New Castle County families the lives of their loved ones,” County Executive Matt Meyer said.…

AmeriHealth Caritas Delaware, the managed-care health plan serving Delawareans on Medicaid, now has contracts with all of the major hospital systems in the state. Those enrolled in the plan can now obtain in-network care from the following health systems: Bayhealth (both campuses) Beebe Healthcare Christiana Care Health System (both campuses) Nanticoke Health Services Nemours Children’s…

(AP) — A federal judge has ordered a Delaware-based medical imaging firm to pay $16.2 million for submitting false claims for Medicare reimbursement. The judge on Monday entered a default judgment against Orthopaedic and Neuro Imaging LLC and its owner, Richard Pfarr of Lewes. Pfarr is liable for $6.1 million of the total. Prosecutors requested…

Amazon is diving into health care, teaming up with Warren Buffett’s Berkshire Hathaway and the New York bank JPMorgan Chase, to create a company that helps their U.S. employees find quality care “at a reasonable cost.” The leaders of each company, Amazon’s Jeff Bezos, Buffett, and JPMorgan’s Jamie Dimon, offered few details Tuesday and said…

Incyte’s Delaware portfolio drives global growth

By Roger Morris Special to Delaware Business Times In a little more than 15 years, Alapocas-based pharmaceuticals company Incyte Corp. has grown from its modest beginnings in Palo Alto, California, to becoming a global drug company with annual revenues in excess of $1 billion. Its growth came initially under the leadership of former DuPont Pharmaceuticals…